The estimated Net Worth of Lynne H Brum is at least $488 Mille dollars as of 8 May 2006. Ms. Brum owns over 2,250 units of Yield10 Bioscience Inc stock worth over $52,194 and over the last 21 years she sold YTEN stock worth over $128,849. In addition, she makes $306,700 as Vice President - Planning and Communications at Yield10 Bioscience Inc.
Sign up
Ms. Brum YTEN stock SEC Form 4 insiders trading
Lynne has made over 19 trades of the Yield10 Bioscience Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently she exercised 2,250 units of YTEN stock worth $32,648 on 8 May 2006.
The largest trade she's ever made was exercising 2,250 units of Yield10 Bioscience Inc stock on 8 May 2006 worth over $32,648. On average, Lynne trades about 531 units every 3 days since 2003. As of 8 May 2006 she still owns at least 47,449 units of Yield10 Bioscience Inc stock.
You can see the complete history of Ms. Brum stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Lynne Brum biography
Lynne H. Brum is a Vice President - Planning and Communications of the Company. Ms. Brum has served as vice president, marketing and corporate communications, of the Company since November, 2011. Prior to joining Metabolix, in 2010 to 2011 she was a communications consultant and served in various roles including as a freelance project director for Seidler Bernstein Inc. Ms. Brum served from 2007 to 2009 as an executive vice president at Porter Novelli Life Sciences, a subsidiary of global PR firm, Porter Novelli International. Prior to that, Ms. Brum was responsible for corporate communications, investor relations and brand management for Vertex Pharmaceuticals, Inc. from 1994 to 2007 in various positions, including vice president of strategic communications. Ms. Brum was also a vice president at Feinstein Kean Healthcare and was part of the communications team at Biogen, Inc. (now Biogen Idec). Ms. Brum holds a bachelor's degree in biological sciences from Wellesley College and a master's degree in business administration from Simmons College's School of Management.
What is the salary of Lynne Brum?
As the Vice President - Planning and Communications of Yield10 Bioscience Inc, the total compensation of Lynne Brum at Yield10 Bioscience Inc is $306,700. There are 2 executives at Yield10 Bioscience Inc getting paid more, with Joseph Shaulson having the highest compensation of $1,394,220.
How old is Lynne Brum?
Lynne Brum is 52, she's been the Vice President - Planning and Communications of Yield10 Bioscience Inc since 2016. There are 6 older and 1 younger executives at Yield10 Bioscience Inc. The oldest executive at Yield10 Bioscience Inc is Anthony Sinskey, 77, who is the Independent Director.
What's Lynne Brum's mailing address?
Lynne's mailing address filed with the SEC is C/O YIELD10 BIOSCIENCE, INC., 19 PRESIDENTIAL WAY, SUITE 201, WOBURN, MA, 01801.
Insiders trading at Yield10 Bioscience Inc
Over the last 8 years, insiders at Yield10 Bioscience Inc have traded over $1,212,006 worth of Yield10 Bioscience Inc stock and bought 4,271,174 units worth $10,113,836 . The most active insiders traders include Jack W Schuler, Peter N Kellogg e Joseph H Shaulson. On average, Yield10 Bioscience Inc executives and independent directors trade stock every 107 days with the average trade being worth of $238,638. The most recent stock trade was executed by Jack W Schuler on 20 December 2023, trading 36,000 units of YTEN stock currently worth $7,200.
What does Yield10 Bioscience Inc do?
yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.
What does Yield10 Bioscience Inc's logo look like?
Complete history of Ms. Brum stock trades at Vertex Pharmaceuticals e Yield10 Bioscience Inc
Yield10 Bioscience Inc executives and stock owners
Yield10 Bioscience Inc executives and other stock owners filed with the SEC include:
-
Joseph Shaulson,
Director -
Oliver Peoples,
President, Chief Executive Officer, Director -
Lynne Brum,
Vice President - Planning and Communications -
Charles Haaser,
Chief Accounting Officer, Vice President - Finance -
Anthony Sinskey,
Independent Director -
Richard Hamilton,
Director -
Sherri Brown,
Director -
Sarah Cecil,
General Counsel, Secretary -
Kristi Snell,
Chief Science Officer, Vice President - Research -
Robert Van Nostrand,
Chairman of the Board, Independent Director -
Peter N Kellogg,
Director -
Jack W Schuler,
-
Willie Loh,
Director